What is the best approach for managing recurrent bacterial vaginosis?

Journal of Family Practice

Volumn 53, Issue 8, 2004, Pages 650-652

  Alfonsi, Grace A ^a   Shlay, Judith C ^a   Parker, Sandi ^b  

^a DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CLINDAMYCIN; METRONIDAZOLE;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; ENDOMETRITIS; EVIDENCE BASED MEDICINE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LACTOBACILLUS ACIDOPHILUS; LOW BIRTH WEIGHT; META ANALYSIS; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RECURRENT INFECTION; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; SYMPTOM; TREATMENT FAILURE; VAGINITIS;

ANTI-INFECTIVE AGENTS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; METRONIDAZOLE; RECURRENCE; RISK FACTORS; VAGINOSIS, BACTERIAL;

EID: 4043123414     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Koumans EH, Markowitz LE, Hogan V. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin Infect Dis 2002; 35(Suppl 2):S152-172.
2. Kane KY, Pierce R. What are the most effective treatments for bacterial vaginosis in nonpregnant women? J Fam Pract 2001; 50:399-400.
3. McDonald H, Brocklehurst P, Parsons J, Vigneswaran R. Cochrane Pregnancy and Childbirth Group. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 1, 2004. Last accessed May 18, 2004.
4. Allen-Davis JT, Beck A, Parker R, Ellis JL, Polley D. Assessment of vulvovaginal complaints: accuracy of telephone triage and in-office diagnosis. Obstet Gynecol 2002; 99:18-22.
5. Shalev E, Battino S, Wiener E, Colodner R, Keness Y. Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996; 5:593-596.
6. Ness RB, Hillier SL, Richter HE, Soper DE, Stamm C, McGregor J, et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 2002; 100:765-772.
7. Marrazzo JM, Koutsky LA, Eschenbach DA, Agnew K, Stine K, Hillier SL. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis 2002; 185:1307-1313.
8. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51(RR-6):1-78.
9. Sobel J. Overview of Vaginitis. In: UpToDate, Rose, BD (Ed). Wellesley, Mass: UpToDate, 2003. (This topic was last changed on July 24, 2003).
10. National guideline for the management of bacterial vaginosis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect 1999; 75 Suppl 1:S16-18.
11. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22.